ORTHO-ATI Trademark

Trademark Overview

On Wednesday, January 30, 2019, a trademark application was filed for ORTHO-ATI with the United States Patent and Trademark Office. The USPTO has given the ORTHO-ATI trademark a serial number of 79253512. The federal status of this trademark filing is REGISTERED as of Tuesday, September 15, 2020. This trademark is owned by Orthocell Limited. The ORTHO-ATI trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services, including those relating to biomechanical and cellular therapeutic medical techniques in the field of regeneration of bone and soft tissue, namely the provision of cell therapies using tendon derived cells for the treatment of chronic degenerative tendon injuries

Scientific and technological research and design services relating to biomechanical and cellular therapeutic medical techniques in the field of the regeneration of bone and soft tissue, namely research and design services relating to cell therapies for the treatment of chronic degenerative tendon injuries
ortho-ati

General Information

Serial Number79253512
Word MarkORTHO-ATI
Filing DateWednesday, January 30, 2019
Status700 - REGISTERED
Status DateTuesday, September 15, 2020
Registration Number6149916
Registration DateTuesday, September 15, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements

Goods and ServicesMedical services, including those relating to biomechanical and cellular therapeutic medical techniques in the field of regeneration of bone and soft tissue, namely the provision of cell therapies using tendon derived cells for the treatment of chronic degenerative tendon injuries
Goods and ServicesScientific and technological research and design services relating to biomechanical and cellular therapeutic medical techniques in the field of the regeneration of bone and soft tissue, namely research and design services relating to cell therapies for the treatment of chronic degenerative tendon injuries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 11, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 11, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrthocell Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU
Party NameOrthocell Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU
Party NameOrthocell Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events

Event DateEvent Description
Wednesday, April 10, 2019ASSIGNED TO EXAMINER
Thursday, March 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 15, 2019APPLICATION FILING RECEIPT MAILED
Thursday, April 18, 2019NON-FINAL ACTION WRITTEN
Friday, April 19, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, May 11, 2019REFUSAL PROCESSED BY MPU
Saturday, May 11, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 1, 2019REFUSAL PROCESSED BY IB
Friday, November 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 8, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 8, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 13, 2020FINAL REFUSAL WRITTEN
Monday, January 13, 2020FINAL REFUSAL E-MAILED
Monday, January 13, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 20, 2020DIVISIONAL REQUEST RECEIVED
Monday, January 20, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 19, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 21, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, February 26, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 26, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 26, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 3, 2020NOTIFICATION PROCESSED BY IB
Wednesday, May 27, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 10, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 10, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 26, 2020NOTIFICATION PROCESSED BY IB
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 15, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, January 29, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, February 16, 2021IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Friday, March 5, 2021IRREGULARITY FROM IB EXAMINED BY MPU
Saturday, August 7, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 12, 2020NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 12, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, August 29, 2020NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, November 28, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 29, 2021GENERIC MADRID TRANSACTION SENT TO IB
Monday, September 15, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Related Keywords

ortho relating tendon medical services therapies cell treatment degenerative design research